Vanda Pharmaceuticals

VNDANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$311.685 M

$5.16 +0.49%

Close of 21 Sept 2026

Revenue

$216.1M

#2261 by revenue

Earnings

-$220.5M

Loss-making

Shares outstanding

60,462,687

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#233InflaRxIFRX$312.4M
#234Q32 BioQTTB$311.7M
#235Vanda PharmaceuticalsVNDA$311.7M
#236Upstream BioUPB$293.8M
#237Fulcrum TherapeuticsFULC$289.9M

What if Vanda Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$500,706.40

Per share 97,130× higher

Bitcoin $1.72T

$28,444.05

Per share 5,518× higher

Nvidia $5.48T

$90,632.06

Per share 17,581× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Vanda Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.